Thrombosis Canada
@thrombosiscan.bsky.social
56 followers 40 following 74 posts
Thrombosis Canada promotes excellent patient care and improved outcomes, for patients with thrombosis, through high-quality knowledge translation, educational resources and point-of-care guidance for diverse groups of healthcare professionals, as we
Posts Media Videos Starter Packs
Pinned
thrombosiscan.bsky.social
Join us on October 25 for a packed day of thrombosis education for healthcare professionals. Register today at thrombosiscanada.ca/2025Conference
thrombosiscan.bsky.social
Rejoignez-nous le lundi 29 septembre pour notre webinaire gratuit et accrédité destiné aux professionnels de la santé, intitulé « Cancer, caillots et communication ». Ce programme sera présenté en français.
thrombosiscan.bsky.social
One month to go before the Thrombosis Canada conference. Conveniently located at the Hilton Toronto Airport Hotel, it's easy to get to if you are from out of town, with lots of parking and no commuting downdown. Great content, accreditation and networking that will support your practice and patients
thrombosiscan.bsky.social
SVT in pregnancy: often dismissed, but potentially dangerous. Are we missing the risks — and opportunities to act? Learn where the gaps are at #TCConf2025 with Dr Camille Simard at.
thrombosiscanada.ca/2025Conference on October 25 in Toronto. Register now.
thrombosiscan.bsky.social
D-dimer: more false positives with age. But does an age-adjusted cutoff finally solve the problem? See what the ADJUST-DVT study found when we hear from Dr Gregoire Le Gal at thrombosiscanada.ca/2025Conference on October 25 in Toronto. Register today. Don't miss out.
thrombosiscan.bsky.social
AF in dialysis patients: stroke vs bleeding risk is a nightmare. Are DOACs safe here? Should we anticoagulate at all? Hear the latest evidence at #TCConf2025 with Dr Thomas Mavrakanas.
thrombosiscanada.ca/2025Conference Register today.
thrombosiscan.bsky.social
Blood clots are one of the most common, and overlooked, complications of cancer
Join leading experts for Cancer, Clots and Communication, a free, accredited webinar that will share the latest information on CAT
Eng: Sept 17, Fr: Sept 29, 7:00–8:00 p.m.
Register: thrombosiscanada.ca/Cancer-Clots...
thrombosiscan.bsky.social
If you’re not at #TC2025, you’ll be hearing about it after. Be in the room where it happens. Register today: thrombosiscanada.ca/2025Conference
thrombosiscan.bsky.social
Low health literacy is common in pediatric VTE and linked to management challenges. This episode of CLOT Conversations highlights why a “universal precautions” approach is key in thrombosis care. Listen today: www.buzzsprout.com/1946680/epis...
thrombosiscan.bsky.social
Early-bird pricing ends Sept 15 — but more importantly, seats are going fast. The 2025 Thrombosis Canada Conference is where new science meets clinical practice. Secure your place today: thrombosiscanada.ca/2025Conference
thrombosiscan.bsky.social
Early bird registration for the Thrombosis Canada Conference ends soon! Secure your spot now! For more information and to register visit: thrombosiscanada.ca/2025Conference
#Thrombosis2025 #MedicalConference
thrombosiscan.bsky.social
#TCConf2025 brings together experts from across Canada to share the latest evidence, debate controversies, and deliver hands-on workshops that impact daily practice.
Don’t miss your chance to learn, collaborate, and shape the future of patient care.
Register now: thrombosiscanada.ca/2025Conference
thrombosiscan.bsky.social
Intermediate risk PE: admit or discharge? Two experts. Opposite views. One heated debate.
What would YOU do? Don’t miss this showdown at #TCConf2025.
thrombosiscanada.ca/2025Conference
thrombosiscan.bsky.social
Not all DOACs are equal.
The COBRA trial pits rivaroxaban vs apixaban in acute VTE.
See who comes out on top — and what it means for your patients. Join us on October 25 as Dr Lana Castellucci shares the results of this impactful research.
Register: thrombosiscanada.ca/2025Conference
thrombosiscan.bsky.social
Post-PE syndrome is common in adults — but much less so in children. The latest episode of CLOT Conversations reviews new data, clinical follow-up strategies, and the importance of encouraging safe physical activity in pediatric PE survivors.
Full episode here: www.buzzsprout.com/1946680/epis...
Children and PE: Outcomes You Need to Know - L. Avila and J. Vincelli - CLOT Conversations
In this episode, Dr. Laura Avila and Jennifer Vincelli discuss their Blood publication on long-term outcomes of pediatric pulmonary embolism. Among 150 patients, ~30% had incomplete PE resolution and…
www.buzzsprout.com
thrombosiscan.bsky.social
Four questions. Four answers. Rapid fire.
🩸TXA: pro-thrombotic?
🩸Breakthrough VTE: what next?
🩸Post-stenting management?
🩸 When to thrombolyse DVT?
Find out in 40 minutes at #TCConf2025.
Register: thrombosiscanada.ca/2025Conference
thrombosiscan.bsky.social
Anticoagulation in cirrhosis: lifesaving or dangerous? The line between thrombosis prevention and catastrophic bleeding is thin. Join Dr. Amber Afzal to navigate this dilemma. Register for our accredited conference today. thrombosiscanada.ca/2025Conference #TCConf2025
thrombosiscan.bsky.social
Think DOACs replaced warfarin for AF? Think again. In special populations — APS, rheumatic AF, obesity, frailty — warfarin still wins. Revisit the “old” with fresh evidence. Register to attend the #TCConf2025 at thrombosiscanada.ca/2025Conference
thrombosiscan.bsky.social
What happens after a PE in children? A Blood cohort study of 150 patients found that while recurrence and transient impairments occur, true long-term complications are rare. Listen to our discussion with Dr. Laura Avila and Jennifer Vincelli on CLOT Conversations: www.buzzsprout.com/1946680/epis...
Children and PE: Outcomes You Need to Know - L. Avila and J. Vincelli - CLOT Conversations
In this episode, Dr. Laura Avila and Jennifer Vincelli discuss their Blood publication on long-term outcomes of pediatric pulmonary embolism. Among 150 patients, ~30% had incomplete PE resolution and…
www.buzzsprout.com
thrombosiscan.bsky.social
Warfarin wasn’t always safe. Heparin wasn’t always predictable. How did we get from dangerous beginnings to modern precision? Dr. Hirsh reveals the fascinating story at #TCConf2025. Register now: thrombosiscanada.ca/2025Conference #KnowThrombosis
thrombosiscan.bsky.social
From leeches to low molecular weight heparin to DOACs — anticoagulation has come a long way. But what lessons from the past still shape how we treat patients today?
Join Dr. Jack Hirsh at #TCConf2025. Register today at thrombosiscanada.ca/2025Conference
thrombosiscan.bsky.social
The 2025 Thrombosis Canada Conference brings together experts to examine how past evidence shapes today’s best practice, and where the future of thrombosis medicine is headed. Join us on October 25 for evidence-based updates, interactive workshops, and networking. Register today: buff.ly/CUEMmDj